FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis
byThe Mount Sinai HospitalEndoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Cre
Updated on: January 25,2024
20

FDA approves mirikizumab, a promising induction and maintenance therapy for ulcerative colitis
byThe Mount Sinai HospitalEndoscopic image of a bowel section known as the sigmoid colon afflicted with ulcerative colitis. The internal surface of the colon is blotchy and broken in places. Cre
Updated on:January 25,2024
20
